Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

APAC Infectious Disease Diagnosis Treatment Companies

Companies in the Asia Pacific region focused on infectious disease diagnosis and treatment play a crucial role in advancing healthcare and addressing public health challenges. These companies engage in the development, manufacturing, and distribution of diagnostic tools, treatments, and preventive measures to combat infectious diseases prevalent in the region.

Infectious Disease Diagnosis & Treatment Companies

Latest APAC Infectious Disease Diagnosis & Treatment Companies Update

Oct 2023:Ahead of government price talks for its best-selling cancer treatment Imbruvica, AbbVie announced on Friday a $2.1 billion charge associated with anticipated revenue declines following the implementation of the new price for Medicare patients in the United States. With a declared government objective of saving $25 billion annually on prescription costs by 2031, the Illinois-based drugmaker's leukemia medicine was chosen in August as one of the 10 drugs subjected to the first-ever price discussions by U.S. Medicare insurance plans. While the first ten medicine prices are still up for negotiation and will not be implemented until 2026, AbbVie claimed to have projected "a substantial reduction in the estimated future financial flows" from the first ten drug prices since it had utilized an undisclosed placeholder price. The prescribed medications are some of the most expensive for the Medicare program, which covers Americans 65 and older. Imbruvica's third-quarter sales of $908 million were above Wall Street's projections of $863 million.

Oct 2023: Pfizer reported its first quarterly loss before 2019 and recommended investors concentrate on growth in non-COVID goods, including the novel RSV vaccine Abrysvo. A decline hit the drugmaker in demand for COVID-19 vaccines and therapies. The business announced last month that it would take a one-time charge of $5.6 billion to cover the returns of thousands of doses of its antiviral medication Paxlovid by the US government and the inventory of COVID vaccination Comirnaty.

List of APAC Infectious Disease Diagnosis & Treatment Companies in the market

Pfizer Inc. (US)

Bristol-Myers Squibb Company (US)

Janssen Global Services LLC (US)

Eli Lilly and Company (US)

Ortho Clinical Diagnostics (US)

Merck & Co. Inc. (US)

AbbVie Inc. (US)

Hoffmann-La Roche Ltd (Switzerland)

Novartis AG (Switzerland)

Aurobindo Pharma (India)

Bayer AG (Germany)

Reddy's Laboratories (India)

Sanofi (France)

Cipla Inc. (India)

APAC Infectious Disease Diagnosis Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.